Mirati Therapeutics to Present New Research From its Innovative Oncology Pipeline at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced new clinical and preclinical research...
Peter Olson Priyanka Shah Jamesg Christensen Temre Johnson Exchange Commission Virtual International Conference On Molecular
Source: prnewswire.com